Concepts (110)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Celiac Disease | 11 | 2022 | 202 | 4.630 |
Why?
|
Diet, Gluten-Free | 9 | 2022 | 52 | 3.230 |
Why?
|
Glutens | 4 | 2022 | 76 | 1.290 |
Why?
|
Wheat Hypersensitivity | 2 | 2017 | 4 | 1.110 |
Why?
|
Triticum | 2 | 2017 | 32 | 1.090 |
Why?
|
Capsule Endoscopy | 1 | 2021 | 33 | 0.800 |
Why?
|
Gliadin | 1 | 2019 | 17 | 0.710 |
Why?
|
Gastroenterology | 1 | 2021 | 134 | 0.700 |
Why?
|
Child | 11 | 2021 | 6913 | 0.650 |
Why?
|
Child, Preschool | 8 | 2021 | 3608 | 0.590 |
Why?
|
Gastrointestinal Diseases | 1 | 2017 | 145 | 0.530 |
Why?
|
Choledochostomy | 1 | 2015 | 8 | 0.530 |
Why?
|
Cholestasis, Intrahepatic | 1 | 2015 | 17 | 0.530 |
Why?
|
Bile Acids and Salts | 1 | 2015 | 60 | 0.510 |
Why?
|
Gastric Emptying | 1 | 2013 | 23 | 0.480 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2014 | 78 | 0.480 |
Why?
|
Gastroparesis | 1 | 2013 | 14 | 0.470 |
Why?
|
Leiomyosarcoma | 1 | 2014 | 40 | 0.470 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2014 | 50 | 0.470 |
Why?
|
Lymphoproliferative Disorders | 1 | 2014 | 107 | 0.460 |
Why?
|
Liver | 2 | 2016 | 1229 | 0.460 |
Why?
|
Herpesvirus 4, Human | 1 | 2014 | 114 | 0.460 |
Why?
|
Infant | 6 | 2021 | 3036 | 0.450 |
Why?
|
Nausea | 1 | 2013 | 175 | 0.420 |
Why?
|
Adolescent | 8 | 2020 | 8968 | 0.390 |
Why?
|
Liver Transplantation | 2 | 2015 | 1263 | 0.340 |
Why?
|
Retrospective Studies | 7 | 2021 | 8431 | 0.290 |
Why?
|
Humans | 18 | 2022 | 86281 | 0.280 |
Why?
|
Infant, Newborn | 4 | 2021 | 2369 | 0.280 |
Why?
|
Body Mass Index | 2 | 2020 | 770 | 0.280 |
Why?
|
Follow-Up Studies | 3 | 2018 | 3616 | 0.260 |
Why?
|
Postoperative Complications | 1 | 2014 | 2183 | 0.230 |
Why?
|
Cross-Sectional Studies | 2 | 2020 | 1610 | 0.210 |
Why?
|
Selenium | 1 | 2021 | 44 | 0.200 |
Why?
|
Inflammation | 2 | 2019 | 913 | 0.200 |
Why?
|
Treatment Outcome | 3 | 2018 | 7949 | 0.200 |
Why?
|
Female | 9 | 2020 | 44405 | 0.190 |
Why?
|
Fellowships and Scholarships | 1 | 2021 | 107 | 0.190 |
Why?
|
Endoscopy, Gastrointestinal | 1 | 2021 | 152 | 0.190 |
Why?
|
Severity of Illness Index | 2 | 2018 | 1796 | 0.190 |
Why?
|
Nutritional Status | 1 | 2020 | 83 | 0.190 |
Why?
|
Thinness | 1 | 2020 | 43 | 0.190 |
Why?
|
Italy | 1 | 2020 | 106 | 0.190 |
Why?
|
Transglutaminases | 1 | 2019 | 39 | 0.180 |
Why?
|
Overweight | 1 | 2020 | 118 | 0.170 |
Why?
|
Male | 7 | 2020 | 40860 | 0.170 |
Why?
|
GTP-Binding Proteins | 1 | 2019 | 146 | 0.170 |
Why?
|
Body Weight | 1 | 2020 | 459 | 0.170 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 1 | 2019 | 101 | 0.160 |
Why?
|
Feeding Behavior | 1 | 2020 | 324 | 0.160 |
Why?
|
Time Factors | 2 | 2018 | 5198 | 0.150 |
Why?
|
Immunoglobulin E | 1 | 2017 | 143 | 0.140 |
Why?
|
Remission Induction | 1 | 2018 | 722 | 0.140 |
Why?
|
Obesity | 2 | 2020 | 962 | 0.140 |
Why?
|
Patient Compliance | 1 | 2018 | 226 | 0.140 |
Why?
|
Milk Proteins | 1 | 2016 | 24 | 0.140 |
Why?
|
Infant Formula | 1 | 2016 | 17 | 0.140 |
Why?
|
Prevalence | 1 | 2020 | 1239 | 0.140 |
Why?
|
End Stage Liver Disease | 1 | 2016 | 61 | 0.140 |
Why?
|
Milk Hypersensitivity | 1 | 2016 | 10 | 0.140 |
Why?
|
Syndrome | 1 | 2017 | 446 | 0.140 |
Why?
|
Clinical Competence | 1 | 2021 | 750 | 0.140 |
Why?
|
Chicago | 1 | 2020 | 1377 | 0.130 |
Why?
|
Risk Factors | 2 | 2018 | 5397 | 0.130 |
Why?
|
Diagnosis, Differential | 2 | 2017 | 1562 | 0.130 |
Why?
|
Bile Canaliculi | 1 | 2015 | 1 | 0.130 |
Why?
|
Radioisotope Dilution Technique | 1 | 2015 | 6 | 0.130 |
Why?
|
Deuterium | 1 | 2015 | 33 | 0.130 |
Why?
|
Bile Ducts, Intrahepatic | 1 | 2015 | 70 | 0.130 |
Why?
|
Jejunum | 1 | 2015 | 78 | 0.130 |
Why?
|
Hydrophobic and Hydrophilic Interactions | 1 | 2015 | 91 | 0.130 |
Why?
|
Adolescent Health | 1 | 2014 | 5 | 0.130 |
Why?
|
Liver Cirrhosis | 1 | 2016 | 296 | 0.120 |
Why?
|
Young Adult | 2 | 2017 | 5961 | 0.120 |
Why?
|
Infant, Premature | 1 | 2016 | 287 | 0.120 |
Why?
|
Intestines | 1 | 2017 | 407 | 0.120 |
Why?
|
Rituximab | 1 | 2014 | 116 | 0.120 |
Why?
|
Age Factors | 1 | 2018 | 1842 | 0.120 |
Why?
|
Environment | 1 | 2014 | 219 | 0.110 |
Why?
|
Immunologic Factors | 1 | 2014 | 170 | 0.110 |
Why?
|
Kinetics | 1 | 2015 | 1513 | 0.110 |
Why?
|
Illinois | 1 | 2013 | 461 | 0.110 |
Why?
|
Comorbidity | 1 | 2014 | 943 | 0.100 |
Why?
|
Surveys and Questionnaires | 2 | 2019 | 2495 | 0.090 |
Why?
|
Incidence | 1 | 2013 | 1568 | 0.090 |
Why?
|
Parenteral Nutrition | 2 | 2021 | 60 | 0.080 |
Why?
|
Adult | 3 | 2017 | 25577 | 0.080 |
Why?
|
Enteral Nutrition | 2 | 2021 | 102 | 0.080 |
Why?
|
Aged, 80 and over | 1 | 2017 | 6481 | 0.070 |
Why?
|
Intestinal Mucosa | 2 | 2022 | 788 | 0.070 |
Why?
|
Genetic Predisposition to Disease | 1 | 2014 | 2267 | 0.070 |
Why?
|
Duodenum | 1 | 2022 | 99 | 0.050 |
Why?
|
Infant, Extremely Low Birth Weight | 1 | 2021 | 26 | 0.050 |
Why?
|
Infant, Very Low Birth Weight | 1 | 2021 | 52 | 0.050 |
Why?
|
Aged | 1 | 2017 | 18353 | 0.050 |
Why?
|
Butyrophilins | 1 | 2019 | 22 | 0.040 |
Why?
|
Intraepithelial Lymphocytes | 1 | 2019 | 16 | 0.040 |
Why?
|
Biopsy | 1 | 2022 | 1160 | 0.040 |
Why?
|
Middle Aged | 1 | 2017 | 24957 | 0.040 |
Why?
|
Antigens | 1 | 2019 | 228 | 0.040 |
Why?
|
HEK293 Cells | 1 | 2019 | 615 | 0.040 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2019 | 371 | 0.040 |
Why?
|
Protein Hydrolysates | 1 | 2016 | 9 | 0.040 |
Why?
|
Milk | 1 | 2016 | 53 | 0.030 |
Why?
|
Birth Weight | 1 | 2016 | 144 | 0.030 |
Why?
|
Cattle | 1 | 2016 | 374 | 0.030 |
Why?
|
Chronic Disease | 1 | 2019 | 968 | 0.030 |
Why?
|
Amino Acids | 1 | 2016 | 252 | 0.030 |
Why?
|
Enterocolitis, Necrotizing | 1 | 2016 | 78 | 0.030 |
Why?
|
Animals | 1 | 2016 | 26518 | 0.010 |
Why?
|